ArticleCancer immunology, immunotherapy : CII2026
Intracranially injected chimeric antigen receptor T cells eradicate glioblastoma cells but have limited potential to persist in the brain in a syngeneic mouse model.
Koki Murakami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.